Author/Authors :
Kirsten Bibbins-Domingo، نويسنده , , Kirsten and Lin، نويسنده , , Feng and Vittinghoff، نويسنده , , Eric and Barrett-Connor، نويسنده , , Elizabeth and Hulley، نويسنده , , Stephen B. and Grady، نويسنده , , Deborah and Shlipak، نويسنده , , Michael G.، نويسنده ,
Abstract :
Randomized, controlled trial data from the Heart and Estrogen-progestin Replacement Study were used to evaluate the effect of estrogen plus progestin use on all-cause mortality in women with heart failure and coronary disease. Over the 4.1-year follow-up, estrogen plus progestin use had no effect on all-cause mortality (hazard ratio 1.0, 95% confidence interval 0.7 to 1.4, p = 0.8) in women with heart failure and coronary disease.
